One of the top reasons that consumers turn to cosmetic procedures is because they want to look as young as they feel or because they want to look better for their age, according to a recent survey by the American Society for Dermatologic Surgery (ASDS)1. The most common sign of aging for men and women alike is the formation of rhytides and wrinkles—it's no surprise then that wrinkle reduction continues to be among the most popular treatments in today's aesthetic market.
Venus Concept offers a variety of different devices that provide non-invasive wrinkle reduction for all skin types with no downtime. From entry-level systems to more advanced, multi-treatment platforms, we have something that will fit the needs of your business while enabling a high ROI.
An easy-to-use system with advanced safety features for non-invasive wrinkle reduction*, which leads to tightening of the skin.
An advanced system to non-invasively address challenging aesthetic concerns for the face and body, including wrinkle reduction and cellulite reduction*.
A versatile multi-applicator platform with three different, highly effective technologies in one workstation to address many of today's most challenging aesthetic concerns. The DiamondPolar™ applicator is powered by Multi-Polar Radio Frequency and Pulsed Electro Magnetic Fields to achieve wrinkle reduction and subsequent tightening of the skin*.
INDICATIONS FOR USE:
*Venus Freeze Plus™ is a non-invasive device cleared by the FDA for use in dermatologic and general surgical procedures for females for the treatment of moderate to severe facial wrinkles and rhytides in Fitzpatrick skin types I-IV, using the DiamondPolar™ and OctiPolar™ applicators.
*Venus Legacy™ is cleared by the FDA for the non-invasive treatment of moderate to severe facial wrinkles and rhytides in females with Fitzpatrick skin types I-IV with the OctiPolar™ and DiamondPolar™ applicators, and temporary reduction in the appearance of cellulite with the 4D Body (LB2) and 4D Face (LF2) applicators.
*Venus Versa™ is cleared by the FDA as a multi-application device intended to be used in aesthetic and cosmetic procedures. The SR515 and SR580 applicators are cleared by the FDA for the treatment of benign pigmented epidermal and cutaneous lesions and treatment of benign cutaneous vascular lesions. The HR650/HR650XL and HR690/HR690XL applicators are cleared by the FDA for the removal of unwanted hair and to effect stable long-term or permanent hair reduction for Fitzpatrick skin types I-IV. The AC Dual applicator is cleared by the FDA for the treatment of acne vulgaris. The DiamondPolar™ and OctiPolar™ applicators on the Venus Versa™ system are cleared by the FDA for non-invasive treatment of moderate to severe facial wrinkles and rhytides on females with Fitzpatrick skin types I-IV. The NanoFractional RF™ (Viva) applicator is cleared by the FDA for dermatological procedures requiring ablation and resurfacing of the skin.
1. American Society for Dermatologic Surgery (ASDS) 2018 Consumer Survey on Cosmetic Dermatologic Procedures. Data were collected from 3,525 consumers through a blind online survey in 2018.